GR67304B - - Google Patents

Info

Publication number: GR67304B
Authority: GR; Greece
Prior art keywords: alkyl; group; aryl; independently selected; substituents
Prior art date: 1979-01-08

Application number

GR60828A

Other languages

English (en)

Inventor

Jan Vandenberg

Ludo E I Kennis

Marcel J M C Van

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-01-08

Filing date

1979-12-21

Publication date

1981-06-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26669096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR67304(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1979-12-21 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1981-06-29 Publication of GR67304B publication Critical patent/GR67304B/el

Links

125000000217 alkyl group Chemical group 0.000 abstract 7
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
125000003118 aryl group Chemical group 0.000 abstract 3
125000001424 substituent group Chemical group 0.000 abstract 3
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
125000002947 alkylene group Chemical group 0.000 abstract 2
125000001475 halogen functional group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229940076279 serotonin Drugs 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GR60828A 1979-01-08 1979-12-21 GR67304B (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US149379A	1979-01-08	1979-01-08
US06/084,272 US4335127A (en)	1979-01-08	1979-10-12	Piperidinylalkyl quinazoline compounds, composition and method of use

Publications (1)

Publication Number	Publication Date
GR67304B true GR67304B (el)	1981-06-29

Family

ID=26669096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR60828A GR67304B (el)	1979-01-08	1979-12-21

Country Status (32)

Country	Link
US (1)	US4335127A (el)
EP (1)	EP0013612B1 (el)
JP (1)	JPS55105679A (el)
KR (3)	KR850000684B1 (el)
AT (1)	ATE5258T1 (el)
AU (1)	AU536175B2 (el)
CA (1)	CA1132557A (el)
CS (1)	CS223977B2 (el)
CY (1)	CY1252A (el)
DE (1)	DE3065489D1 (el)
DK (1)	DK170669B1 (el)
ES (1)	ES487537A0 (el)
FI (1)	FI66609C (el)
GR (1)	GR67304B (el)
HK (1)	HK76284A (el)
HU (1)	HU184222B (el)
IE (1)	IE49351B1 (el)
IL (1)	IL59084A (el)
LU (1)	LU88219I2 (el)
MA (1)	MA18694A1 (el)
MY (1)	MY8700555A (el)
NL (1)	NL930018I2 (el)
NO (1)	NO155243C (el)
NZ (1)	NZ192551A (el)
PH (1)	PH17114A (el)
PL (1)	PL125789B1 (el)
PT (1)	PT70662A (el)
RO (1)	RO79148A (el)
SG (1)	SG48684G (el)
SU (1)	SU1041034A3 (el)
YU (1)	YU42957B (el)
ZA (1)	ZA8082B (el)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA806501B (en) *	1979-10-27	1981-10-28	Richardson Merrell Inc	4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
CA1183847A (en) *	1981-10-01	1985-03-12	Georges Van Daele	N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US4355037A (en) *	1981-11-12	1982-10-19	Hoechst-Roussel Pharmaceuticals	3-(4-Piperidyl)-1,2-benzisoxales
DK159420C (da) *	1983-03-09	1991-03-11	Ciba Geigy Ag	N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
ZA841728B (en) *	1983-03-09	1984-11-28	Ciba Geigy Ag	Novel carboxamides
JPS608274A (ja) *	1983-06-27	1985-01-17	Fujisawa Pharmaceut Co Ltd	新規キナゾリノン誘導体およびその製造法・並びに抗アレルギ−剤
PH23995A (en) *	1984-01-09	1990-02-09	Janssen Pharmaceutica Nv	4((bicycle heterocyclyl)-methyl and hetero)piperidines
CS247557B1 (en) *	1984-04-06	1987-01-15	Ludmila Fisnerova	Esters of 3-(2-hydroxyethyl)-4(3h)-quinazolinone
EP0177078A1 (en) *	1984-09-12	1986-04-09	Duphar International Research B.V	Spasmolytically active tertiary amine derivatives and method of preparing the same
US4634769A (en) *	1984-09-25	1987-01-06	Ortho Pharmaceutical Corporation	Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
US4665075A (en) *	1984-12-05	1987-05-12	Janssen Pharmaceutica N.V.	Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
CA1246074A (en) *	1984-12-05	1988-12-06	Albertus H.M.T. Van Heertum	Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JPH0615529B2 (ja) *	1985-04-01	1994-03-02	エーザイ株式会社	新規ピペリジン誘導体
FR2581993B1 (fr) *	1985-05-14	1988-03-18	Synthelabo	Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4753944A (en) *	1985-11-04	1988-06-28	American Cyanamid Company	Pharmaceutical methods of using 3-heteroarylalkyl-4-quinazolinones
US4710502A (en) *	1985-11-04	1987-12-01	American Cyanamid Company	3-heteroarylalkyl-4-quinazolinones
DK623586A (da) *	1985-12-27	1987-06-28	Eisai Co Ltd	Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
ATE146077T1 (de) *	1986-09-22	1996-12-15	Janssen Pharmaceutica Nv	Serotonin-antagonisten zur behandlung von wunden
US4874766A (en) *	1986-09-22	1989-10-17	Janssen Pharmaceutica N.V.	Method of promoting wound-healing
AU593194B2 (en) *	1986-09-26	1990-02-01	Sumitomo Pharmaceuticals Company, Limited	Imide derivatives ,and their production and use
JPH0434361Y2 (el) *	1986-12-25	1992-08-17
DE3738844A1 (de) *	1987-11-16	1989-05-24	Merck Patent Gmbh	Analgetikum
ES2087072T3 (es) *	1988-03-28	1996-07-16	Janssen Pharmaceutica Nv	Agentes para conservar o restablecer la salud de la piel.
IL90879A0 (en) *	1988-09-02	1990-02-09	Janssen Pharmaceutica Nv	3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
CA1340821C (en) *	1988-10-06	1999-11-16	Nobuyuki Fukazawa	Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
FR2644786B1 (fr) *	1989-03-21	1993-12-31	Adir Cie	Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2744634B2 (ja) *	1989-04-14	1998-04-28	三菱重工業株式会社	ゴミ焼却装置
US5364866A (en)	1989-05-19	1994-11-15	Hoechst-Roussel Pharmaceuticals, Inc.	Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) *	1989-05-19	1998-07-07	Hoechst Marion Roussel, Inc.	3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5561128A (en) *	1989-05-19	1996-10-01	Hoechst-Roussel Pharmaceuticals, Inc.	N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
IE913473A1 (en) *	1990-10-15	1992-04-22	Fujisawa Pharmaceutical Co	Quinazoline derivatives and their preparation
US5158953A (en) *	1991-08-13	1992-10-27	National Science Council	2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
DE4138756A1 (de) *	1991-11-26	1993-05-27	Troponwerke Gmbh & Co Kg	Kombination mit neuroprotektiver wirkung
US5266571A (en) *	1992-01-09	1993-11-30	Amer Moh Samir	Treatment of hemorrhoids with 5-HT2 antagonists
GB9202915D0 (en) *	1992-02-12	1992-03-25	Wellcome Found	Chemical compounds
PT626968E (pt) *	1992-02-13	2002-03-28	Merrell Pharma Inc	Derivados de piperidinilo tiaciclicos
FR2696744B1 (fr) *	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
CA2124306C (en) *	1993-05-26	2004-04-06	Masami Muraoka	Quinazolinone derivatives
EP0729357B1 (en) *	1993-11-19	2005-02-02	Janssen Pharmaceutica N.V.	Microencapsulated 1,2-benzazoles
EP0661266A1 (en) *	1993-12-27	1995-07-05	Toa Eiyo Ltd.	Substituted cyclic amine compounds as 5HT2 antagonists
US6184377B1 (en)	1997-12-15	2001-02-06	Sepracor Inc.	Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
PT1122253E (pt) *	1998-10-16	2005-11-30	Sumitomo Pharma	Derivados de quinazolinona
GB9903784D0 (en) *	1999-02-18	1999-04-14	Lilly Co Eli	Pharmaceutical compounds
CA2361366A1 (en) *	1999-03-26	2000-10-05	Nicholas Kindon	Novel compounds
US6476041B1 (en) *	1999-10-29	2002-11-05	Merck & Co., Inc.	1,4 substituted piperidinyl NMDA/NR2B antagonists
GB2362381A (en) *	2000-05-18	2001-11-21	Lilly Co Eli	Pharmaceutically active indolyl-piperidines
US6844338B2 (en)	2000-05-18	2005-01-18	Eli Lilly And Company	Piperidyindoles as serotonin receptor ligands
GB0013060D0 (en) *	2000-05-31	2000-07-19	Astrazeneca Ab	Chemical compounds
GB0021670D0 (en) *	2000-09-04	2000-10-18	Astrazeneca Ab	Chemical compounds
DE10101324C1 (de) *	2001-01-13	2001-12-13	Ibfb Gmbh Privates Inst Fuer B	1-Dimercaptoalkylchinazolin-2,4-(1H,3H)-dione als Matrix-Metalloproteinase(MMP)-Inhibitoren
GB0117899D0 (en) *	2001-07-23	2001-09-12	Astrazeneca Ab	Chemical compounds
SE0102809D0 (sv) *	2001-08-22	2001-08-22	Astrazeneca Ab	Novel compounds
GB0126433D0 (en) *	2001-11-03	2002-01-02	Astrazeneca Ab	Compounds
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
AU2003288017A1 (en) *	2002-11-13	2004-06-03	Synthon B.V.	Process for making risperidone and intermediates therefor
GB0309009D0 (en) *	2003-04-22	2003-05-28	Astrazeneca Ab	Quinazoline derivatives
WO2004094414A1 (en) *	2003-04-22	2004-11-04	Synthon B.V.	Water soluble salts of risperidone
GB0309850D0 (en) *	2003-04-30	2003-06-04	Astrazeneca Ab	Quinazoline derivatives
GB0321648D0 (en) *	2003-09-16	2003-10-15	Astrazeneca Ab	Quinazoline derivatives
PL1667991T3 (pl) *	2003-09-16	2008-12-31	Astrazeneca Ab	Pochodne chinazoliny jako inhibitory kinazy tyrozynowej
WO2005026156A1 (en) *	2003-09-16	2005-03-24	Astrazeneca Ab	Quinazoline derivatives
EP1664028A1 (en) *	2003-09-16	2006-06-07	AstraZeneca AB	Quinazoline derivatives as tyrosine kinase inhibitors
EP1670782B1 (en) *	2003-09-19	2007-02-14	AstraZeneca AB	Quinazoline derivatives
WO2005028469A1 (en) *	2003-09-19	2005-03-31	Astrazeneca Ab	Quinazoline derivatives
GB0322409D0 (en) *	2003-09-25	2003-10-29	Astrazeneca Ab	Quinazoline derivatives
WO2005030757A1 (en) *	2003-09-25	2005-04-07	Astrazeneca Ab	Quinazoline derivatives
JP2007509095A (ja) *	2003-10-24	2007-04-12	エフ．ホフマン−ラ　ロシュ　アーゲー	Ｃｃｒ３受容体アンタゴニスト
GB0326459D0 (en) *	2003-11-13	2003-12-17	Astrazeneca Ab	Quinazoline derivatives
US7855207B2 (en)	2003-11-20	2010-12-21	Janssen Pharmaceutica, Nv	6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
ES2551027T3 (es) *	2003-11-20	2015-11-13	Janssen Pharmaceutica Nv	2-Quinolinonas 7-fenilalquil sustituidas y 2-quinoxalinonas como inhibidores de poli(ADP-ribosa) polimerasa
NZ547193A (en) *	2003-12-05	2010-03-26	Janssen Pharmaceutica Nv	6-Substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
US7632840B2 (en) *	2004-02-03	2009-12-15	Astrazeneca Ab	Quinazoline compounds for the treatment of hyperproliferative disorders
EP1756088A1 (en) *	2004-06-04	2007-02-28	AstraZeneca AB	Quinazoline derivatives as erbb receptor tyrosine kinases
JP4969443B2 (ja) *	2004-06-30	2012-07-04	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｐａｒｐ阻害剤としてのキナゾリノン誘導体
NZ551801A (en) *	2004-06-30	2009-11-27	Janssen Pharmaceutica Nv	Quinazolinedione derivatives as PARP inhibitors
MXPA06014542A (es) *	2004-06-30	2007-03-23	Janssen Pharmaceutica Nv	Derivados de ftalazina como inhibidores de poli(adp-ribosa) polimerasa-i.
CN101124228B (zh)	2004-12-14	2011-06-15	阿斯利康(瑞典)有限公司	用作抗肿瘤药物的吡唑并嘧啶化合物
CA2599210A1 (en) *	2005-02-26	2006-08-31	Astrazeneca Ab	Quinazoline derivatives as tyrosine kinase inhibitors
GB0504474D0 (en) *	2005-03-04	2005-04-13	Astrazeneca Ab	Chemical compounds
GB0508717D0 (en) *	2005-04-29	2005-06-08	Astrazeneca Ab	Chemical compounds
GB0508715D0 (en) *	2005-04-29	2005-06-08	Astrazeneca Ab	Chemical compounds
WO2007034143A1 (en) *	2005-09-20	2007-03-29	Astrazeneca Ab	Quinazoline derivatives as anticancer agents
JP2009508918A (ja) *	2005-09-20	2009-03-05	アストラゼネカアクチボラグ	癌治療のためのｅｒｂＢ受容体チロシンキナーゼ阻害剤としての４−（１Ｈ−インダゾール−５−イル］アミノ）キナゾリン化合物
WO2007063291A1 (en) *	2005-12-02	2007-06-07	Astrazeneca Ab	4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
US20090029968A1 (en) *	2005-12-02	2009-01-29	Bernard Christophe Barlaam	Quinazoline derivatives used as inhibitors of erbb tyrosine kinase
EP1921070A1 (de) *	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
MX2009007610A (es) *	2007-02-06	2009-07-24	Boehringer Ingelheim Int	Heterociclicos biciclicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.
WO2008107478A1 (en)	2007-03-08	2008-09-12	Janssen Pharmaceutica Nv	Quinolinone derivatives as parp and tank inhibitors
EP2215075B1 (en) *	2007-10-26	2013-12-11	Janssen Pharmaceutica, N.V.	Quinolinone derivatives as parp inhibitors
PT2245026E (pt) *	2008-02-07	2012-10-15	Boehringer Ingelheim Int	Heterociclos espirocíclicos, produtos farmacêuticos contendo estes compostos, sua utilização e processo para a sua preparação
WO2009118384A1 (en) *	2008-03-27	2009-10-01	Janssen Pharmaceutica Nv	Quinazolinone derivatives as tubulin polymerization inhibitors
ES2529545T3 (es)	2008-03-27	2015-02-23	Janssen Pharmaceutica, N.V.	Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerización de tubulina y PARP
EA019183B1 (ru) *	2008-05-13	2014-01-30	Астразенека Аб	Фумаратная соль 4-(3-хлор-2-фторанилино)-7-метокси-6-{[1-(n-метилкарбамоилметил)пиперидин-4-ил]окси}хиназолина
JP5539351B2 (ja) *	2008-08-08	2014-07-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	シクロヘキシルオキシ置換ヘテロ環、これらの化合物を含有する医薬、およびそれらを生成するための方法
CU24130B1 (es)	2009-12-22	2015-09-29	Novartis Ag	Isoquinolinonas y quinazolinonas sustituidas
US8440693B2 (en) *	2009-12-22	2013-05-14	Novartis Ag	Substituted isoquinolinones and quinazolinones
BRPI1003506B1 (pt)	2010-09-24	2019-12-03	Ache Int Bvi Ltd	composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
JP6171003B2 (ja)	2012-05-24	2017-07-26	ノバルティスアーゲー	ピロロピロリジノン化合物
WO2014115080A1 (en)	2013-01-22	2014-07-31	Novartis Ag	Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the p53/mdm2 interaction
US9403827B2 (en)	2013-01-22	2016-08-02	Novartis Ag	Substituted purinone compounds
WO2014191894A1 (en)	2013-05-27	2014-12-04	Novartis Ag	Imidazopyrrolidinone derivatives and their use in the treatment of disease
CA2912986A1 (en)	2013-05-28	2014-12-04	Novartis Ag	Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
MX2015016425A (es)	2013-05-28	2016-03-03	Novartis Ag	Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
EA029269B1 (ru)	2013-11-21	2018-02-28	Новартис Аг	Производные пирролопирролона и их применение для лечения заболеваний
EP3317278B1 (en)	2015-07-01	2021-04-14	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
CN106866625B (zh) *	2017-01-17	2019-12-13	上海鼎雅药物化学科技有限公司	酮色林的制备方法
EP3658560A4 (en)	2017-07-25	2021-01-06	Crinetics Pharmaceuticals, Inc.	SOMATOSTAT IN MODULATORS AND USES THEREOF
CN109157507A (zh) *	2018-09-14	2019-01-08	上海禾丰制药有限公司	酒石酸酮色林注射液及其制备方法
CN112142760A (zh) *	2020-10-20	2020-12-29	江苏法安德医药科技有限公司	一种酮色林中间体以及酮色林的制备方法
WO2023133524A1 (en) *	2022-01-06	2023-07-13	Terran Biosciences, Inc.	A process for synthesizing ketanserin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3322766A (en) *	1964-11-13	1967-05-30	Shulton Inc	3-beta-(4-pyridyl) ethyl-2, 3-dihydro-4(1h)-quinazolinones
US3635976A (en) *	1967-12-20	1972-01-18	Pennwalt Corp	1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US4096144A (en) *	1970-12-08	1978-06-20	Sumitomo Chemical Company, Limited	Process for preparing quinazolinone derivatives and their 2-(N-mono-substituted amino)-phenyl ketone intermediate derivatives
US4099002A (en) *	1970-12-23	1978-07-04	Sumitomo Chemical Company, Limited	Quinazolinone derivatives and a process for production thereof
US4146717A (en) *	1972-04-07	1979-03-27	Sumitomo Chemical Company, Limited	Nitroquinazolinone compounds having antiviral properties
US4035369A (en) *	1975-10-08	1977-07-12	Janssen Pharmaceutica N.V.	1-Benzazolylalkyl-4-substituted-piperidines

1979
- 1979-10-12 US US06/084,272 patent/US4335127A/en not_active Expired - Lifetime
- 1979-12-21 GR GR60828A patent/GR67304B/el unknown
1980
- 1980-01-04 MA MA18891A patent/MA18694A1/fr unknown
- 1980-01-07 NO NO800034A patent/NO155243C/no unknown
- 1980-01-07 IL IL59084A patent/IL59084A/xx unknown
- 1980-01-07 FI FI800047A patent/FI66609C/fi not_active IP Right Cessation
- 1980-01-07 PL PL1980221249A patent/PL125789B1/pl unknown
- 1980-01-07 LU LU88219C patent/LU88219I2/xx unknown
- 1980-01-07 SU SU802863403A patent/SU1041034A3/ru active
- 1980-01-07 DK DK007280A patent/DK170669B1/da not_active IP Right Cessation
- 1980-01-07 AT AT80300059T patent/ATE5258T1/de not_active IP Right Cessation
- 1980-01-07 CS CS80157A patent/CS223977B2/cs unknown
- 1980-01-07 CA CA343,181A patent/CA1132557A/en not_active Expired
- 1980-01-07 IE IE21/80A patent/IE49351B1/en not_active IP Right Cessation
- 1980-01-07 CY CY1252A patent/CY1252A/xx unknown
- 1980-01-07 EP EP80300059A patent/EP0013612B1/en not_active Expired
- 1980-01-07 AU AU54381/80A patent/AU536175B2/en not_active Expired
- 1980-01-07 ZA ZA00800082A patent/ZA8082B/xx unknown
- 1980-01-07 PT PT70662A patent/PT70662A/pt unknown
- 1980-01-07 DE DE8080300059T patent/DE3065489D1/de not_active Expired
- 1980-01-07 NZ NZ192551A patent/NZ192551A/en unknown
- 1980-01-07 JP JP18680A patent/JPS55105679A/ja active Granted
- 1980-01-07 HU HU8025A patent/HU184222B/hu unknown
- 1980-01-08 YU YU46/80A patent/YU42957B/xx unknown
- 1980-01-08 ES ES487537A patent/ES487537A0/es active Granted
- 1980-01-08 PH PH23489A patent/PH17114A/en unknown
- 1980-01-21 KR KR1019800000201A patent/KR850000684B1/ko active
- 1980-02-20 RO RO80100248A patent/RO79148A/ro unknown
1984
- 1984-07-06 SG SG486/84A patent/SG48684G/en unknown
- 1984-08-02 KR KR1019840004608A patent/KR850000677B1/ko not_active IP Right Cessation
- 1984-10-11 HK HK762/84A patent/HK76284A/xx not_active IP Right Cessation
- 1984-12-20 KR KR1019840008162A patent/KR850000683B1/ko not_active IP Right Cessation
1987
- 1987-12-30 MY MY555/87A patent/MY8700555A/xx unknown
1993
- 1993-03-02 NL NL930018C patent/NL930018I2/nl unknown

Also Published As

Publication number	Publication date
PT70662A (en)	1980-02-01
HK76284A (en)	1984-10-19
KR850000683B1 (ko)	1985-05-14
DK7280A (da)	1980-07-09
YU42957B (en)	1989-02-28
LU88219I2 (el)	1994-02-03
US4335127A (en)	1982-06-15
HU184222B (en)	1984-07-30
ATE5258T1 (de)	1983-11-15
RO79148A (ro)	1982-08-17
MA18694A1 (fr)	1980-10-01
JPS6346753B2 (el)	1988-09-19
CS223977B2 (en)	1983-11-25
DK170669B1 (da)	1995-11-27
PL221249A1 (el)	1980-12-01
IE49351B1 (en)	1985-09-18
CA1132557A (en)	1982-09-28
SU1041034A3 (ru)	1983-09-07
AU536175B2 (en)	1984-04-19
IL59084A (en)	1984-02-29
NO800034L (no)	1980-07-09
KR850002015A (ko)	1985-04-10
FI800047A (fi)	1980-07-09
SG48684G (en)	1985-03-29
NZ192551A (en)	1984-07-06
NL930018I2 (nl)	1993-09-16
PL125789B1 (en)	1983-06-30
JPS55105679A (en)	1980-08-13
ES8101586A1 (es)	1980-12-16
ZA8082B (en)	1981-08-26
NO155243C (no)	1987-03-04
EP0013612B1 (en)	1983-11-09
YU4680A (en)	1983-06-30
KR850000684B1 (ko)	1985-05-14
FI66609C (fi)	1984-11-12
DE3065489D1 (en)	1983-12-15
KR830001926A (ko)	1983-05-19
NL930018I1 (nl)	1993-05-03
PH17114A (en)	1984-06-01
ES487537A0 (es)	1980-12-16
EP0013612A3 (en)	1980-10-15
KR850000677B1 (ko)	1985-05-10
NO155243B (no)	1986-11-24
FI66609B (fi)	1984-07-31
EP0013612A2 (en)	1980-07-23
CY1252A (en)	1984-08-31
IL59084A0 (en)	1980-05-30
IE800021L (en)	1980-07-08
MY8700555A (en)	1987-12-31
AU5438180A (en)	1980-07-17

Publication	Publication Date	Title
AU536175B2 (en)	1984-04-19	(piperidinylalky) quinazoline derivatives
HK1087112A1 (en)	2006-10-06	Tricyclic compounds, their production and use
ES8504719A1 (es)	1985-05-01	Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
IE780577L (en)	1978-09-24	Propanolamines
ES8103749A1 (es)	1981-03-16	Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas
AU557502B2 (en)	1986-12-24	Dithiino(1,4)(2,3-c)pyrrole derivatives
DE3775905D1 (de)	1992-02-20	Purin-histamin-h1-antagonisten, ihre herstellung und sie enthaltende pharmazeutische praeparate.